rs141507441
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001384732.1(CPLANE1):c.8872C>T(p.Arg2958*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,613,420 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001384732.1 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPLANE1 | NM_001384732.1 | c.8872C>T | p.Arg2958* | stop_gained | 47/53 | ENST00000651892.2 | NP_001371661.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPLANE1 | ENST00000651892.2 | c.8872C>T | p.Arg2958* | stop_gained | 47/53 | NM_001384732.1 | ENSP00000498265.2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151874Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251214Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135778
GnomAD4 exome AF: 0.0000335 AC: 49AN: 1461546Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727072
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151874Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74142
ClinVar
Submissions by phenotype
Joubert syndrome 17 Pathogenic:3Other:1
Pathogenic, criteria provided, single submitter | research | UW Hindbrain Malformation Research Program, University of Washington | Feb 23, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | Jun 22, 2023 | The stop gained c.8872C>T (p.Arg2958Ter) variant in the CPLANE1 gene has been observed in individual(s) with Joubert syndrome (Bachmann-Gagescu, R et al., 2015). This variant is reported with the allele frequency (0.003%) in the gnomAD Exomes. It is submitted to ClinVar as Pathogenic (multiple submissions). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Computational evidence (MutationTaster - Disease causing) predicts damaging effect on protein structure and function for this variant. The nucleotide change c.8872C>T in CPLANE1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic. In the absence of another reportable variant, the molecular diagnosis is not confirmed. - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | May 06, 2021 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a likely mechanism of disease in this gene and is associated with Joubert syndrome 17 (MIM#614615) and orofaciodigital syndrome VI (MIM#277170) (OMIM). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v2: 9 heterozygotes, 0 homozygotes). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. There are at least nine pathogenic NMD-predicted variants that have been previously reported (ClinVar, Decipher, PMID: 29605658) (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported in five individuals diagnosed with Joubert syndrome or skeletal dysplasia (ClinVar, PMIDs: 25920555; 30408610; 32233090). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1201 - Heterozygous variant detected in trans with a second pathogenic heterozygous variant (NM_023073.3 (CPLANE1): c.2932C>T; p.A(rg978*)) in a recessive disease. (SP) 1206 - This variant has been shown to be paternally inherited. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 22, 2023 | This sequence change creates a premature translational stop signal (p.Arg2904*) in the CPLANE1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CPLANE1 are known to be pathogenic (PMID: 24178751, 26092869). This variant is present in population databases (rs141507441, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with Joubert syndrome (PMID: 25920555, 26092869). ClinVar contains an entry for this variant (Variation ID: 217571). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 14, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30408610, 31130284, 32233090, 25920555) - |
Pathogenic, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | May 01, 2022 | DNA sequence analysis of the CPLANE1 gene demonstrated a sequence change, c.8710C>T, in exon 46 that results in the creation of a premature stop codon at amino acid position 2904, p.Arg2904*. This sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated CPLANE1 protein with potentially abnormal function. This sequence change has been described in the gnomAD database with a frequency of 0.0057% in the Latino/Admixed American subpopulation (dbSNP rs141507441). This pathogenic sequence change has previously been described in several individuals with CPLANE1-related disorders in the homozygous or compound heterozygous state (PMID: 25920555, 32233090). Pathogenic variants in CPLANE1 are associated with autosomal recessive Joubert syndrome and autosomal recessive Orofaciodigital syndrome VI [OMIM# 614571]. The CPLANE1 cDNA reference sequence used is NM_023073.3. - |
Orofaciodigital syndrome type 6;C3553264:Joubert syndrome 17 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 11, 2022 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 31, 2021 | The c.8710C>T (p.R2904*) alteration, located in exon 46 (coding exon 45) of the C5orf42 gene, consists of a C to T substitution at nucleotide position 8710. This changes the amino acid from a arginine (R) to a stop codon at amino acid position 2904. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This mutation has been reported in the homozygous or compound heterozygous state in several individuals with a diagnosis of CPLANE1-related ciliopathy (Kroes, 2016; Monies, 2019; Liu, 2020). Based on the available evidence, this alteration is classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at